Reify Health, which makes cloud-based tools for clinical trial research, raises $220M Series C led by Coatue Management at a $2.2B valuation (Kyle LaHucik/FierceBiotech)

Kyle LaHucik / FierceBiotech:Reify Health, which makes cloud-based tools for clinical trial research, raises $220M Series C led by Coatue Management at a $2.2B valuation  —  The COVID-19 pandemic emphasized the need for quicker clinical trial enrollment and more decentralized studies to assuage safety concerns.

Reify Health, which makes cloud-based tools for clinical trial research, raises $220M Series C led by Coatue Management at a $2.2B valuation (Kyle LaHucik/FierceBiotech)

Kyle LaHucik / FierceBiotech:
Reify Health, which makes cloud-based tools for clinical trial research, raises $220M Series C led by Coatue Management at a $2.2B valuation  —  The COVID-19 pandemic emphasized the need for quicker clinical trial enrollment and more decentralized studies to assuage safety concerns.